Clinical Trial Update: StrataGraft Safety, Tolerability and Efficacy in Pediatric Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating StrataGraft for safety, tolerability, and efficacy in pediatric burn and skin wound patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns
• Skin Wound
• Trauma-related Wound

Drugs mentioned

• StrataGraft

Snippet

Sponsor: Stratatech, a Mallinckrodt Company | Conditions: Skin Wound, Burns | Phase 3 | Status: COMPLETED | Results posted: 2025-03-18